期刊文献+

神经节苷脂联合高压氧治疗新生儿缺血缺氧性脑病临床分析 被引量:12

神经节苷脂联合高压氧治疗新生儿缺血缺氧性脑病临床分析
暂未订购
导出
摘要 目的:探讨神经节苷脂联合高压氧治疗新生儿缺血缺氧性脑病(HIE)的临床疗效。方法:将收治的50例HIE患儿,随机分为治疗组26例,对照组24例。治疗组在对照组吸氧、保温、控制惊厥、降颅压、防治感染和支持疗法等的基础上,给予神经节苷脂和高压氧联合治疗措施。结果:治疗组显效19例,有效6例,总有效率为96.15%,对照组显效11例,有效10例,总有效率为87.5%,两组总有效率比较差异有统计学意义(X2=4.36,P<0.05)。结论:神经节苷脂联合高压氧治疗新生儿缺氧缺血性脑病疗效显著,不良反应少,安全有效。 Objective:To explore clinical curative effect of ganglioside(GA) and high pressure oxygen(HPO) on treating Hypoxie-ischemic encephalopathy(HIE).Method:Divided randomly 26 cases of 50 HIE children into treatment group,and 24 into control group.Give the treatment group GA and HPO treatment more while both of the two groups are treated with oxygen,thermal insulation,control of seizures,reducing the intracranial pressure,infection prevention and supportive therapy.Result:19 cases in the treatment group have reaction,and 6 cases effective,with 6.15% total effective rate.While 11 cases in the control group have reaction,and 6 cases effective,with 87.5% total effective rate Statistically significant of the total effective rate Difference between the two group(X2=4.36,P<0.05).Conclusions:The clinical curative effect of GA and HPO on treating HIE is distinct.They have fewer side effects and are safe and sure.So they are worthy of clinical use.
作者 刘廷亮
出处 《中国社区医师(医学专业)》 2013年第10期200-201,共2页
关键词 新生儿缺氧缺血性病 神经节苷脂 高压氧 疗效 Hypoxie-ischemic encephalopathy(HIE) Ganglioside(GA) High pressure oxygen(HPO) Curative effect
  • 相关文献

参考文献5

二级参考文献22

  • 1吴婉芳,徐放生,张莉莉,蔡玲玲,林久治.建立新生儿缺氧缺血性脑病动物模型[J].中国新生儿科杂志,1992,17(6):265-267. 被引量:128
  • 2[1]Ledeen RW, Wu GS, Lu ZH, et al. The role of GMl and other gangliosides in neuronal differentiation: overview and new finding. Ann N Y Acad Sci 1998, 845: 161-175.
  • 3[2]Silva RH, Bergamo M, Vital BMBF, et al. Effects of neonatal GM1 administration on the discrimination avoidance behavior of adult rats. Ann N Y Acad Sci 1998, 845: 45-53.
  • 4[3]Ando S, Tanaka Y, Waki H, et al. Gangliosides and sialycholesterol as of synaotic functions. Ann N Y Acad Sci 1998, 845:232-239.
  • 5[4]Schengnmd CL, Mummert CM. Exogenous glanglisides: How do they cross the blood-brain barrier and how do they inhibit cell proliferation? Ann N Y Acad Sci 1998, 845:279-283.
  • 6[5]Frontczak-Baniewicz M, Gadasmki R, Barskov 1, et al. Beneficial effects of GM1 ganglioside on photochemically-induced microvascular injury in cerebral cortex and hypophysis in rat.Exp Toxicol Pathol, 2000, 52(2): 111-118.
  • 7[6]Simon RP, Chen J, Graham SH. GM1 ganglioside treatment of focal ischemia: a dose-response and microdialvsis study. J Pharmacol Exp Ther 1993, 265(1): 24-29.
  • 8[7]Krajnc D, Wemlinger TA, Neff NH, et d. Neonatal hypoxia:early neurotransmitter responses and the consequences of treatment with GM1 ganglioside. J Pharmacol Exp Ther 1994, 271(3): 1299-1306.
  • 9[8]Garofalo L, Cuello A. Nerve growth factor and the monosialoganglioside GM 1: analogous and different in vivo effects on biochemical, morphological, and behavioral paramenters of adult cortically lesioned rats. Exp Neurol 1994, 125: 195-217.
  • 10[9]Rabin S J, Mocchetti J. GM1 ganglioside activaes the high-affmity nerve growth factor receptor TekA. J Neuroch 1995, 65:347-354.

共引文献411

同被引文献68

引证文献12

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部